Marathon Patent Group Inc  

(Public, NASDAQ:MARA)   Watch this stock  
Find more results for mara
1.39
+0.04 (2.96%)
Nov 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.34 - 1.46
52 week 0.50 - 9.80
Open 1.35
Vol / Avg. 504,937.00/482,943.00
Mkt cap 10.81M
P/E     -
Div/yield     -
EPS -9.47
Shares 7.78M
Beta 2.07
Inst. own 7%

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -619.70% -78.70%
Operating margin -794.12% -42.54%
EBITD margin - 22.30%
Return on average assets -65.50% -88.01%
Return on average equity - -1613.89%
Employees 6 -
CDP Score - -

Address

11100 Santa Monica Blvd Ste 380
LOS ANGELES, CA 90025-1576
United States - Map
+1-800-8041690 (Phone)
+1-703-9977320 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Marathon Patent Group Inc. (MARA) is engaged in acquiring patents and patent rights from owners or other ventures. The Company monetizes its portfolio of patents and patent rights by entering into license discussions. The Company owns around 378 United States and foreign patents, and patent rights across a range of technologies and markets. The Company owns around 22 patent applications across a range of technologies and markets.

Officers and directors

Douglas B. Croxall Chairman of the Board, Chief Executive Officer
Age: 48
Bio & Compensation  - Reuters
Francis P. Knuettel II Chief Financial Officer
Age: 51
Bio & Compensation  - Reuters
James G. Crawford Chief Operating Officer
Age: 42
Bio & Compensation  - Reuters
Bill Easton Chief Technology Officer
Bio & Compensation  - Reuters
David P. Lieberman Director
Age: 68
Bio & Compensation  - Reuters
Merrick D. Okamoto Director
Age: 56
Bio & Compensation  - Reuters
Richard S. Chernicoff Independent Director
Age: 59
Bio & Compensation  - Reuters
Edward Kovalik Independent Director
Age: 42
Bio & Compensation  - Reuters
Christopher James Robichaud Independent Director
Age: 50
Bio & Compensation  - Reuters